Summit Therapeutics Inc. employees and revenue per employee

SMMT · Biotechnology · $7.96B market cap

Summit Therapeutics Inc. had 76 employees at the end of fiscal Dec 2022, down 27.6% from a year earlier. Revenue for the year was $583,190, down 56.4% from a year earlier, or $8K per employee. Revenue fell, and headcount fell or held flat with it.

The latest annual report we hold is more than two years old, so these numbers may be out of date.

Employees

76

-27.6% YoY

Revenue

$583,190

-56.4% YoY

Revenue / employee

$8K

Peer median $455K

Rank in industry

106 of 111

Biotechnology

Open roles

54

711 per 1,000 staff

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2020
83153222'20'21'22Revenue 93Staff 96

Hover a year for the numbers.

SMMT employees and revenue by fiscal year
Year endingEmployeesRevenuePer employeeStaff YoYRevenue YoY
Dec 202276$583,190$8K-27.6%-56.4%
Dec 2021105$1.3M$13K+32.9%+112.7%
Dec 202079$628,875$8K——

Open roles on its job board: 54 (711 per 1,000 staff, against its latest annual headcount), as of 2026-11-20. Tracked since 2026-10-03. No 90 day change yet.

Employees, last six fiscal years
79'20105'2176'22
Revenue per employee, last six fiscal years
$8K'20$13K'21$8K'22

Summit Therapeutics Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

CompanyEmployeesRevenueRevenue / employeeShape
CGON
CG Oncology Inc.
142$4.0M$28KEfficient growth
STTK
Shattuck Labs, Inc.
40$1.0M$25KContracting
DNTH
Dianthus Therapeutics, Inc.
92$2.0M$22KHiring into decline
ABSI
Absci Corporation
140$2.8M$20KContracting
INBX
Inhibrx Biosciences Inc.
109$1.3M$12KLeaner
NGNE
Neurogene Inc.
107$925,000$9K—
SMMT
Summit Therapeutics Inc.
76$583,190$8KContracting
CLDX
Celldex Therapeutics, Inc.
198$1.5M$8KHiring into decline
ARTV
Artiva Biotherapeutics, Inc.
89$251,000$3K—
Every Healthcare company

Questions about Summit Therapeutics Inc.

How many employees does Summit Therapeutics Inc. have?
Summit Therapeutics Inc. reported 76 employees for the fiscal year ending Dec 2022, in the annual report it filed on March 9, 2023. That is down 27.6% from a year earlier.
What is Summit Therapeutics Inc.'s revenue per employee?
Summit Therapeutics Inc. brought in $583,190 of revenue in fiscal Dec 2022, which is $8K per employee. That ranks 106 of 111 companies we track in Biotechnology, where the median is $455K.
Is Summit Therapeutics Inc. hiring?
Summit Therapeutics Inc.'s public job board listed 54 open roles on November 20, 2026, about 711 per 1,000 staff.
Where do these numbers come from?
Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

This page is the filings. The research is a membership.

On the first and third Friday of each month Outpick publishes one stock pick with the full case for owning it, adds it to a live portfolio you can audit, and writes a note when a position closes. A new account gets 21 days of the whole membership with no card, and nothing is charged when it ends.

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

Compare SMMT with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Source: employee counts and revenue as stated in Summit Therapeutics Inc.'s annual reports (Form 10-K), latest filed March 9, 2023. This is data, not a recommendation to buy or sell SMMT.